Q1 2024 · 13F-HR
Foresite Capital Management V, LLCholdings as filed
Filed 2024-05-15 · accession 0001104659-24-061748
$106.5M
Reported value
5
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 433000106 | HIMS | Hims & Hers Health, Inc. | $51.5M | 48.3% | 3,326,783 | Common | SOLE |
| 156944100 | CGON | CG Oncology, Inc. | $30.4M | 28.5% | 692,550 | Common | SOLE |
| 254604101 | IRON | Disc Medicine, Inc. | $15.2M | 14.2% | 243,513 | Common | SOLE |
| 49705R105 | KNTEUSD | Kinnate Biopharma Inc. | $9.4M | 8.80% | 3,525,957 | Common | SOLE |
| 90138Q108 | — | 23andMe Holding Co. | $123,530 | 0.12% | 232,200 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.